H. Lundbeck AS is an international pharmaceutical company, which was initially a trading company now engaged in research, development, production, marketing and sale of drugs in the field of psychiatry and neurology, specifically on the treatment of central nervous system disorders. One of the company’s most successful products is citalopram for treating depression and other principal products are Cipralex, Lexapro, Ebixa etc. In 2001, the company had a turn-over of €1030 M.